Omicron, a new variant of the SARS-CoV-2 coronavirus, will infect nearly 40% of the world’s population.
Pfizer
Posted inCOVID-19, Infections, New Drugs, Regulatory
Paxlovid Approved in the U.S.
Pfizer’s oral antiviral drug has entered the world’s main pharmaceutical market.
Posted inInfections, New Drugs, Regulatory
Apretude: New Drug to Prevent HIV Infection
Injecting cabotegravir once every two months will high effectively protect against HIV infection.
Posted inCOVID-19, Infections, Research
Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments
Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Voxzogo: First Drug to Treat Dwarfism
Vosoritide by BioMarin Pharmaceutical may cure achondroplasia.
Posted inInfections, New Drugs, Regulatory
Prevnar 20: New Pneumococcal Vaccine
Pfizer has released an updated and improved version of Prevnar 13, a popular pneumococcal vaccine.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Koselugo: First Drug to Treat Neurofibromatosis
Selumetinib by AstraZeneca powerfully suppresses tumor growth in neurofibromatosis type 1.